Henry O. Gosebruch

Chief Strategy Officer, AbbVie.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

As of each latest filing. The line shows shares held over time.

Recent filings

  • Aug 19, 2026Granted 6,662 shares of ANI PHARMACEUTICALS INC7
  • May 21, 2025Returned to company 50,000 shares of ACELYRIN, Inc.9
  • Feb 14, 2024Granted 80,000 shares of Neumora Therapeutics, Inc.8
  • Sep 19, 2023Bought 15,000 shares at $12.62 of Neumora Therapeutics, Inc.10
  • May 9, 2023Bought 50,000 shares at $18.00 of ACELYRIN, Inc.11
  • May 16, 2022Sold 83,960 shares at $155.00 of AbbVie12
  • May 16, 2022Sold 83,960 shares at $155.00 of AbbVie13
  • May 16, 2022Exercised options 83,960 shares at $54.86 of AbbVie12
  • May 16, 2022Exercised options 83,960 shares at $54.86 of AbbVie13
  • Mar 1, 2022Sold 100 shares at $149.38 of AbbVie14
  • Mar 1, 2022Sold 1,101 shares at $149.14 of AbbVie15
  • Mar 1, 2022Sold 100 shares at $149.38 of AbbVie6
  • Mar 1, 2022Sold 4,000 shares at $148.71 of AbbVie14
  • Mar 1, 2022Sold 8,303 shares at $148.62 of AbbVie15
  • Mar 1, 2022Sold 4,000 shares at $148.71 of AbbVie6
  • Mar 1, 2022Sold 5,167 shares at $147.60 of AbbVie14
  • Mar 1, 2022Sold 5,596 shares at $147.54 of AbbVie15
  • Mar 1, 2022Sold 5,167 shares at $147.60 of AbbVie6
  • Mar 1, 2022Sold 15,733 shares at $146.81 of AbbVie14
  • Mar 1, 2022Sold 15,733 shares at $146.81 of AbbVie6
  • Feb 25, 2022Shares withheld for tax 30,156 shares at $149.54 of AbbVie15
  • Feb 17, 2022Granted 8,701 shares of AbbVie16
  • Feb 17, 2022Granted 14,722 shares of AbbVie16
  • Feb 17, 2022Granted 7,972 shares of AbbVie16
  • Feb 17, 2022Granted 36,673 shares of AbbVie16

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16